M Baker

A PHASE I STUDY OF SWAINSONINE IN PATIENTS WITH ADVANCED MALIGNANCIES

Paul E. Goss, Jessica Jean Baptiste, B Fernandes et al. · Journal of Immunotherapy · 1993 · 46 citations

Medicine, Immunology, Oncology +9

Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity

Kapil N. Bhalla, W. Maclaughlin, Joby Cole et al. · Blood · 1987 · 33 citations · Full text

Medicine, Hematology, Oncology +14

A phase II controlled study of a combination of the immune modulator, lentinan, with didanosine (ddI) in HIV patients with CD4 cells of 200-500/mm3.

M Gordon, Mario Guralnik, Y. Kaneko et al. · PubMed · 1995 · 28 citations

Medicine, Infectious Diseases, Pharmacology +17

Measuring swainsonine in serum of cancer patients: phase I clinical trial

José Baptista, Paul E. Goss, Mai P. Nghiem et al. · Clinical Chemistry · 1994 · 18 citations

Medicine, Oncology, Pharmacology +13

Deoxycytidine stimulates the in vitro growth of normal CFU-GM and reverses the negative regulatory effects of acidic isoferritin and prostaglandin E1

Kapil N. Bhalla, Joby Cole, W. Maclaughlin et al. · Blood · 1986 · 12 citations · Full text

Life Sciences, Biochemistry, Cell Biology +3